Overjet is a software company and the developer of an artificial intelligence platform aiming to support dental providers and payers with insights designed to improve clinical treatments and streamline the claims review process. Dental groups, group practices, and dental support organizations use Overjet’s Clinical Intelligence Platform to join clinical AI results in radiographs with patient treatment data with the goal of improving their efficiency and communication and advancing patient results. Their Claim Intelligence Platform strives to help insurance companies more rapidly and accurately approve AI-confirmed claims. Overjet was founded in 2018 and is headquartered in Boston, Massachusetts.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/05/2024 | Series C | $53.2MM | $xx.xx | $550.15MM | March Capital, General Catalyst, Insight Partners, E14 Fund, Crosslink Capital, Spring Rock Capital, Liquid 2 Ventures, Harmonic Growth Partners, American Dental Association | |
Price per Share
$xx.xx
Shares Outstanding
2,108,267
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
March Capital, General Catalyst, Insight Partners, E14 Fund, Crosslink Capital, Spring Rock Capital, Liquid 2 Ventures, Harmonic Growth Partners, American Dental Association
|
||||||
12/20/2021 | Series B | $42.5MM | $xx.xx | $425.05MM | General Catalyst, Insight Partners, Crosslink Capital, E14 Fund | |
Price per Share
$xx.xx
Shares Outstanding
1,782,567
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
General Catalyst, Insight Partners, Crosslink Capital, E14 Fund
|
||||||
08/26/2021 | Series A | $31.5MM | $xx.xx | $113.94MM | General Catalyst, Insight Partners, Crosslink Capital, E14 Fund | |
Price per Share
$xx.xx
Shares Outstanding
4,320,463
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
General Catalyst, Insight Partners, Crosslink Capital, E14 Fund
|
||||||
06/02/2020 | Series Seed-2 | $499,998 | $xx.xx | $22.36MM | Crosslink Capital, E14 Fund, Liquid 2 Ventures, SpringRock Ventures | |
Price per Share
$xx.xx
Shares Outstanding
279,090
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Crosslink Capital, E14 Fund, Liquid 2 Ventures, SpringRock Ventures
|
||||||
06/02/2020 | Series Seed-1 | $1.3MM | $xx.xx | $22.36MM | Crosslink Capital, E14 Fund, Liquid 2 Ventures, SpringRock Ventures | |
Price per Share
$xx.xx
Shares Outstanding
1,762,489
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Crosslink Capital, E14 Fund, Liquid 2 Ventures, SpringRock Ventures
|
||||||
06/02/2020 | Series Seed | $6MM | $xx.xx | $22.36MM | Crosslink Capital, E14 Fund, Liquid 2 Ventures, SpringRock Ventures | |
Price per Share
$xx.xx
Shares Outstanding
3,014,179
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Crosslink Capital, E14 Fund, Liquid 2 Ventures, SpringRock Ventures
|